Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Liver Fibrosis Using FibroScan and Non-invasive Biochemical Markers in Patients Treated With Methotrexate

NCT00673101 is registered in ClinicalTrials.gov with Association HGE CHU Bordeaux Sud as lead sponsor.

NCT NCT00673101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Liver Fibrosis Using FibroScan and Non-invasive Biochemical Markers in Patients Treated With Methotrexate
Lead sponsor
Association HGE CHU Bordeaux Sud
Phase
Observational
Overall status
Completed
Start date
January 31, 2006
Completion date
July 31, 2019
Enrollment
1,871 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis